Page last updated: 2024-08-26

adenosine 5'-methylenediphosphate and B16 Melanoma

adenosine 5'-methylenediphosphate has been researched along with B16 Melanoma in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bigda, JJ; Gołuńska, M; Kolasa, J; Koszałka, P; Pryszlak, A; Składanowski, AC; Stasiłojć, G1
Elima, K; Jalkanen, S; Karikoski, M; Laurila, JP; Marttila-Ichihara, F; Niemelä, J; Salmi, M; Yegutkin, GG1
Curiel, TJ; Fan, J; Shin, T; Thompson, LF; Wang, L; Zhang, B; Zhang, Y1
Adcock, IM; Arra, C; Cicala, C; Forte, G; Luciano, A; Maiolino, P; Montinaro, A; Morello, S; Pinto, A; Sorrentino, R1

Other Studies

4 other study(ies) available for adenosine 5'-methylenediphosphate and B16 Melanoma

ArticleYear
Inhibition of CD73 stimulates the migration and invasion of B16F10 melanoma cells in vitro, but results in impaired angiogenesis and reduced melanoma growth in vivo.
    Oncology reports, 2014, Volume: 31, Issue:2

    Topics: 5'-Nucleotidase; Adenosine Diphosphate; Animals; Antigens, CD; Apyrase; Cell Adhesion; Cell Line, Tumor; Cell Movement; Cell Proliferation; Extracellular Matrix Proteins; HEK293 Cells; Humans; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Invasiveness; Neovascularization, Pathologic; Purinergic P1 Receptor Agonists

2014
Altered purinergic signaling in CD73-deficient mice inhibits tumor progression.
    European journal of immunology, 2011, Volume: 41, Issue:5

    Topics: 5'-Nucleotidase; Adenosine Diphosphate; Adenosine Triphosphatases; Animals; Apyrase; Cell Proliferation; Disease Progression; Interferon-gamma; Lectins, C-Type; Lymphocytes; Lymphocytes, Tumor-Infiltrating; Macrophages; Mannose Receptor; Mannose-Binding Lectins; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Neoplasm Metastasis; Nitric Oxide Synthase Type II; Purines; Receptors, Cell Surface; RNA, Messenger; Signal Transduction; T-Lymphocytes, Regulatory

2011
CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.
    The Journal of clinical investigation, 2011, Volume: 121, Issue:6

    Topics: 5'-Nucleotidase; Adenosine; Adenosine Diphosphate; Animals; Chemotaxis, Leukocyte; Disease Progression; Female; Immunotherapy, Adoptive; Lymphocytes, Tumor-Infiltrating; Lymphoma, Non-Hodgkin; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Molecular Targeted Therapy; Ovarian Neoplasms; Peritoneal Neoplasms; Radiation Chimera; Second Messenger Systems; T-Lymphocytes; T-Lymphocytes, Regulatory; Tumor Burden

2011
Inhibition of CD73 improves B cell-mediated anti-tumor immunity in a mouse model of melanoma.
    Journal of immunology (Baltimore, Md. : 1950), 2012, Sep-01, Volume: 189, Issue:5

    Topics: 5'-Nucleotidase; Adenosine Diphosphate; Animals; Antineoplastic Agents; B-Lymphocytes; Cell Line, Tumor; Cells, Cultured; Disease Models, Animal; Female; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mice, Nude; Th1 Cells; Th17 Cells

2012